Study of Oncoimmunome for the Treatment of Stage III/IV Ovarian Carcinoma

NCT02933073 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
8
Enrollment
OTHER
Sponsor class

Stopped Study recruitment is temporary on hold by the sponsor due to patient recruitment challenges and the ongoing review of the investigational adjuvant.

Conditions

Interventions

Sponsor

UConn Health